Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity

Immunology

Volumn 93, Issue 4, 1998, Pages 511-517

  Gardiner, C M ^a   Reen, D J ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEOXYURIDINE; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 4; PERFORIN;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN K 562; CELL TRANSPLANTATION; CONTROLLED STUDY; DAUDI CELL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFANT; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ADULT; AGING; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENZYME ACTIVATION; FETAL BLOOD; GRANZYMES; HUMANS; INFANT, NEWBORN; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES;

EID: 0031943620     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00464.x     Document Type: Article

References (40)

1. ZYCHLINSKY A., ZHENG L.M., LIU C.C. & YOUNG J.D.E. (1991) Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 146, 393.
2. MASSON D. & TSCHOPP J. (1985) Isolation of a lytic, pore-forming protein (perforin) from cytotoxic T lymphocytes. J Biol Chem 260, 9069.
3. LEE R.K., SPIELMAN J., ZHAO D.Y., OLSEN K.J. & PODACK E.R. (1996) Perforin, Fas ligand, and Tumor Necrosis Factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 157, 1919.
4. LOWIN B., HAHNE M., MATTMANN C. & TSCHOPP J. (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and fas lytic pathways. Nature 370, 650.
5. SHI L., KRAUT R.P., AEBERSOLD R. & GREENBERG A.H. (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175, 553.
6. HEUSEL J.W., WESSELSCHMIDT R.L., SHRESTA S., RUSSELL J.H. & LEY T.J. (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977.
7. TOMEI L.D. & COPE F.O. (1991) In: Apoptosis The Molecular Basis of Cell Death (eds L. D. Tomei & F. O. Cope) p. 1. Cold Spring Harbor Laboratory Press, New York.
8. ANDERSSON U., BIRD A.G., BRITTON S. & PALACIOS R. (1981) Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev 57, 5.
9. WILSON C.B., LEWIS D.B. & PENIX L.A. (1996) Physiologic immunodeficiency of immaturity. In: Immunologic Disorders in Infants and Children (ed. E. R. Stiehm) edn 4, p. 253. WB Saunders, Philadelphia.
10. YABUHARA A., KAWAI H. & KOMIYAMA A. (1990) Development of natural killer cytotoxicity during childhood: marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood. Pediatr Res 28, 316.
11. MONTAGNA D., MACCARIO R., UGAZIO A.G., MINGRAT G. & BURGIO G.R. (1988) Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity. Clin Exp Immunol 71, 177.
12. MALYGIN A.M. & TIMONEN T. (1993) Non-major histocompatability complex-restricted killer cells in human cord blood: generation and cytotoxic activity in recombinant interleukin-2-supplemented cultures. Immunology 79, 506.
13. WAGNER J.E., KERNAN N.A., STEINBUCH M., BROXMEYER H.E. & GLUCKMAN E. (1995) Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346, 214.
14. + cells in SCID mice. Transplant Proc 25, 1227.
15. HERCEND T., TAKVORIAN T., NOWILL A. et al. (1986) Characterisation of natural killer cells with anti-leukaemia activity following allogeneic bone marrow transplantation. Blood 67, 722.
16. GRIMM E.A., ROBB R.J., ROTH J.A. et al. (1983) Lymphokine-activated killer cell phenomenon III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med 158, 1356.
17. ROBERTSON M.J., MANLEY T.J., DONAHUE C., LEVINE H. & RITZ J. (1993) Co-stimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol 150, 1705.
18. TRINCHIERI G. (1989) Co-stimulatory signals are required for optimal proliferation of human natural killer cells. Adv Immunol 47, 187.
19. NAGLER A., LANIER L.L. & PHILLIPS J.H. (1988) The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol 141, 2349.
20. BROOKS B., CHAPMAN K., LAWRY J., MEAGER A. & REES R.C. (1990) Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-β1: effect of addition of exogenous tumour necrosis factor alpha and interferon-gamma, and measurement of their endogenous production. Clin Exp Immunol 82, 583.
21. BOYUM A. (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 27(suppl.), 7.
22. WHITESIDE T., BRYANT J., DAY R. & HERBERMAN R.B. (1990) Natural killer cytotoxicity in the diagnosis of immune dysfunctions: Criteria for a reproducible NK assay. J Clin Lab Anal 4, 102.
23. BRAHMI Z., TOMITA A., HOMMEL-BERREY G., WOODARD G. & MORSE P. (1991) Mouse targets undergo double-strand DNA fragmentation when exposed to syngeneic or xenogeneic LAK cells whereas human targets undergo single-strand breaks. Nat Immun Cell Growth Regul 10, 196.
24. TRAPANI J.A., BROWNE K.A., DAWSON M. & SMYTH M.J. (1993) Immunopurification of functional asp-ase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun 195, 910.
25. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1989) Transfer of proteins from SDS polyacrylamide gels to solid supports: immunological detection of immobilised proteins (western blotting). In: Molecular Cloning, A Laboratory Manual, Vol. 3, p. 18. Cold Spring Harbor Laboratory Press, New York.
26. GRIMM E.A., MAZUMDER A., SHANG H.Z. & ROSENBERG S.A. (1982) Lymphokine-activated killer phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155, 1823.
27. NISHIKAWA K., SAITO S., MORII T. et al. (1990) Differential expression of the interleukin 2 receptor on human peripheral blood natural killer subsets. Int Immunol 2, 481.
28. DUKE R.C., COHEN J.J. & CHERVENAK R. (1986) Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. J Immunol 135, 1442.
29. TUNRU I.S., SUZUKI H. & KOBAYASHI M. (1993) Induction of lymphokine activated killer cells from nude mouse spleen cells by interleukin-4. Experientia 49, 76.
30. HIGUCHI C.M., THOMPSON J.A., LINDGREN C.G. et al. (1989) Induction of lymphokine-activated killer activity by interleukin-4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. Cancer Res 49, 6487.
31. SWISHER S.G., ECONOMOU J.S., CARMACK HOLMES E. & GOLUB S.H. (1990) TNF-α and IFN-γ reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell Immunol 128, 450.
32. ROBINET E., KAMOUN M., FARACE F. & CHOUAIB S. (1992) Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors. Eur J Immunol 22, 2861.
33. ZOLA H., FUSCO M., MACARDLE P.J., FLEGO L. & ROBERTON D. (1995) Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res 38, 397.
34. ZOLA H., FUSCO M., WEEDON H., MACARDLE P.J., RIDINGS J. & ROBERTON D. (1996) Reduced expression of the interleukin-2 receptor γ chain on cord blood lymphocytes: relationship to functional immaturity of the neonatal immune response. Immunology 87, 86.
35. SAITO S., MORII T., UMEKAGE H. et al. (1996) Expression of the interleukin-2 receptor y chain on cord blood mononuclear cells. Blood 87, 3344.
36. LEWIS D.B., YU C.C., MEYER J., ENGLISH B.K., KAHN S.J. & WILSON C.B. (1991) Cellular and molecular mechanisms for reduced interleukin-4 and interferon-γ production by neonatal T cells. J Clin Invest 87, 194.
37. EARLY E.M. & REEN D.J. (1996) Antigen-independent responsiveness to interleukin-4 demonstrates differential regulation of new-born human T cells. Eur J Immunol 26, 2885.
38. BARRIOS C., BRAWAND P., BERNEY M., BRANDT C., LAMBERT P.H. & SIEGRIST C.A. (1996) Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 26, 1489.
39. SMYTH M.J. & TRAPANI J.A. (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 16, 202.
40. SHRESTA S., HEUSEL J.W., MACIVOR D.M., WESSELSCHMIDT R.L., RUSSEL J.H. & LEY T.J. (1995) Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol Rev 146, 211.